[{"title": "Transparent and robust Artificial intelligence-driven Electrocardiogram model for Left Ventricular Systolic Dysfunction", "link": "https://www.medrxiv.org/content/10.1101/2024.10.06.24314872.full.pdf", "details": "JH Jang, MS Lee, S Kang, GI Han, AH Yoo, YY Jo\u2026 - medRxiv, 2024", "abstract": "Heart failure (HF) is an escalating global health concern, worsened by an aging population and limitations in traditional diagnostic methods like electrocardiograms (ECG). The advent of deep learning has shown promise for utilizing 12-lead ECG \u2026"}, {"title": "NT-proBNP Reflects Left Ventricular Hypertrophy Rather than Left Ventricular Dilatation or Systolic Dysfunction in Patients with Fabry Disease", "link": "https://www.mdpi.com/2077-0383/13/19/5953", "details": "C Gatterer, D Beitzke, G Sunder-Plassmann, M Friedl\u2026 - Journal of Clinical Medicine, 2024", "abstract": "Background: The diagnosis and follow-up of cardiac involvement in Fabry disease constitutes an important challenge for clinicians caring for affected patients. Combining cardiac imaging with laboratory biomarkers appears most appropriate for \u2026"}, {"title": "Enabling Medical Therapy for Heart Failure: New Tools Bring a New Reality for Hyperkalemia", "link": "https://www.jacc.org/doi/full/10.1016/j.jacc.2024.05.080", "details": "SJ Greene, A Spahillari, M Shahzeb Khan - Journal of the American College of \u2026, 2024", "abstract": "Despite overwhelming scientific evidence, strong guideline recommendations, and numerous quality improvement initiatives, implementation of disease-modifying medical therapy for heart failure with reduced ejection fraction (HFrEF) has remained \u2026"}]
